News

N G Industries net profit declines 77.57% in the March 2013 quarter
Capital Market/14:15,Jun 17, 2013
Sales rise 14.15% to Rs 3.63 crore

17:55		CDR Health Care reports nil net profit/loss in the March 2013 quarter
12:57		Medinova Diagnostic Services reports net profit of Rs 0.06 crore in the March 2013 quarter
15:32		Dolphin Medical Services reports net loss of Rs 0.25 crore in the March 2013 quarter
12:43		Opto Circuits tumbles to 52-week low on high volume
09:31		Fortis Healthcare in the pink of health

Related Research

	Kishor Patil, MD & CEO, KPIT Cummins
	No rainbow in sight!
	Nothing really!
	Vinod Kumar, Managing Director and CEO, Tata Communications
	The Power of Decision

Calendar

Jun-2013

M	T	W	T	F	S	S
17	18	19	20	21	22	23

Economic Events

ANZ Job Advertisements (MoM)

EIA Natural Gas Storage Change

View full month Economic Events calendar

Results

Havells India | Union Bank (I) | Dena Bank | Central Bank

View full month Results calendar

IPO

No IPO today

View full month IPO calendar

Collapse Markets

Indian Equities

Collapse Sectors

Automobiles & Ancillaries

Banking & Financials

Cap Goods, Eng & Infra

Gems & Jewellery

Hotels & Tourism

Media & Entertainment

Metals, Mining & Minerals

Paper & Packaging

Pharma & Healthcare

Shipping & Shipyard

Collapse Personal Finance

Personal Finance

Collapse Business Houses

Business Houses

Mukesh Ambani Grp

Tata Group News

Aditya Birla Group

Collapse Other News

Collapse Announcements

Analyst Meet/AGM

BSE Announcements

NSE Announcements

Collapse Circulars

NCDEX Circulars

IndiaInfoline

Markets

News

Corporate News

India Infoline News on Twitter

Print | Email| Font Size

Standard Medical & Pharmaceuticals' board approves scheme of amalgamation

Capital Market/ 18:20 , Jan 09, 2012

On 09 January 2012

The board of Standard Medical & Pharmaceuticals in its meeting on 09 January 2012 has approved the scheme of amalgamation of the company with Medinova Diagnostic Services.

Print | Email

Rate This Article

Rate 1

Rate 2

Rate 3

Rate 4

Rate 5

Recent News Videos

Thursday, 20 June 2013 00:51 IST

Connect with IIFL :

Commodity Ideas Stock Ideas IIFL Live Customer Service Corporate News

IIFL Group

Products & Services

Trading

Discuss

Offbeat

Useful Links

Calculators

Glossary:

Accountancy Advertising Budget Commerce Derivatives Economics Finance General Mgmt. HR Mgmt. IT Marketing Material Mgmt.

Stocks:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mutual Funds:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Insurance:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Disclaimer Disclaimer - Research Disclaimer - Discussion Boards Disclaimer - Chat Disclaimer - Twitter Terms & Conditions Privacy Policy

Copyright © India Infoline Ltd. All rights Reserved.
NSE SEBI Registration No. Capital Market:- INB231097537/ INF231097537/ INE231097537, CODE NO: 10975 & TC10975 CM No.: M51058
NSE SEBI Registration No. Derivatives:- INF 231097537 Clearing Member ICICI Bank Ltd. CM-C50006.
BSE SEBI Registration No. Capital Market :-INB011097533 and INF011097533. Clearing No. 179
MCX Stock Exchange Limited - SEBI Registration No: INE 261097537 CODE NO. 22 | NCDEX Membership No. NCDEX-CO-04-00378 | MCX Membership No. 10470

8